I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Vigna, Ernesto
51
results:
OpenAccess-fulltext X
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
Azacitidine Post-Remission Therapy for Elderly Patients wit..:
Oliva, Esther Natalie
;
Candoni, Anna
;
Salutari, Prassede
...
info:eu-repo/semantics/altIdentifier/wos/WOS:000991562000001. , 2023
Link:
https://hdl.handle.net/1..
?
2
Elotuzumab plus pomalidomide and dexamethasone in relapsed/..:
Gentile, Massimo
;
Vigna, Ernesto
;
Palmieri, Salvatore
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772491/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
3
Safe and Effective Administration of Caplacizumab in COVID-..:
Bruzzese, Antonella
;
Vigna, Ernesto
;
Terzi, Dario
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366750/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
4
Elotuzumab plus lenalidomide and dexamethasone in relapsed/..:
Bruzzese, Antonella
;
Derudas, Daniele
;
Galli, Monica
...
info:eu-repo/semantics/altIdentifier/pmid/35608183. , 2022
Link:
http://hdl.handle.net/24..
?
5
Cerebral pheohyphomycosis due to curvularia species:
Bova, Carlo
;
Vigna, Ernesto
;
Gentile, Massimo
.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749271/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
6
Survival Risk Scores for Real-Life Relapsed/Refractory Mult..:
Morabito, Fortunato
;
Zamagni, Elena
;
Conticello, Concetta
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341470/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
7
Survival Risk Scores for Real-Life Relapsed/Refractory Mult..:
Morabito, Fortunato
;
Zamagni, Elena
;
Conticello, Concetta
...
info:eu-repo/semantics/altIdentifier/pmid/35924160. , 2022
Link:
http://hdl.handle.net/10..
?
8
Treatment of Lenalidomide Exposed or Refractory Multiple My..:
Botta, Cirino
;
Martino, Enrica Antonia
;
Conticello, Concetta
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079718/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
9
Adjusted comparison between elotuzumab and carfilzomib in c..:
Morabito, Fortunato
;
Zamagni, Elena
;
Conticello, Concetta
...
info:eu-repo/semantics/altIdentifier/pmid/34716957. , 2021
Link:
http://hdl.handle.net/24..
?
10
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therap..:
Morabito, Fortunato
;
Tripepi, Giovanni
;
Martino, Enrica Antonia
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275138/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
11
Validation of the alternative international prognostic scor..:
Morabito, Fortunato
;
Tripepi, Giovanni
;
Vigna, Ernesto
...
info:eu-repo/semantics/altIdentifier/pmid/33662164. , 2021
Link:
http://hdl.handle.net/24..
?
12
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therap..:
Morabito, Fortunato
;
Tripepi, Giovanni
;
Martino, Enrica Antonia
...
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S295215. , 2021
Link:
https://www.dovepress.co..
?
13
TP53 disruption as a risk factor in the era of targeted the..:
Morabito, Fortunato
;
Del Poeta, Giovanni
;
Mauro, Francesca Romana
...
info:eu-repo/semantics/altIdentifier/pmid/33989438. , 2021
Link:
http://hdl.handle.net/24..
?
14
Elotuzumab, lenalidomide, and dexamethasone as salvage ther..:
Gentile, Massimo
;
Specchia, Giorgina
;
Derudas, Daniele
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776255/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
15
Effectiveness of ibrutinib as first-line therapy for chroni..:
Morabito, Fortunato
;
Tripepi, Giovanni
;
Del Poeta, Giovanni
...
info:eu-repo/semantics/altIdentifier/pmid/33878220. , 2021
Link:
http://hdl.handle.net/24..
1-15